This report examines the growing market for remedies aimed at treating the symptoms of gastro-intestinal ailments such as indigestion, heartburn, constipation, diarrhoea, upset stomachs and irritable bowel syndrome (IBS). Far from being a new market, manufacturers have managed to grow sales quite considerably in recent years. This report therefore explores how this occurred. Major considerations include the consistent investment by manufacturers in new product innovation, high-profile advertising and promotional activity, and importantly, the impact of deregulation, which has seen some previously prescription-only medicines being reclassified for OTC sale.

Using the latest consumer research, market size data and trend analysis, this report provides vital new insight into the current state of the market and its prospects, investigating its drivers, segmentation, supply structure, distribution, advertising spend and sales forecasts.

Mintel’s findings offer you a unique way of understanding consumer trends and the attitudes of the market’s key target audiences, enabling you to tailor your marketing to real demand, both tactically and strategically. Use Mintel’s research to avoid market pitfalls, discover sector opportunities, identify growth potential and achieve the best possible results.